Use of remdesivir for COVID-19 pneumonia in patients with advanced kidney disease: A retrospective multicenter study

BACKGROUND AND OBJECTIVES: Remdesivir, an antiviral drug routinely used in the treatment of COVID-19 has not yet received FDA approval for use in patients with advanced kidney disease defined as GFR < 30 mL/min/1.73 m(2). There is concern that an excipient in Veklury (Gilead’s proprietary name fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Stancampiano, F., Jhawar, N., Alsafi, W., Valery, J., Harris, D.M., Kempaiah, P., Shah, S., Heckman, M.G., Siddiqui, H., Libertin, C.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of British Infection Association. 2022
Materias:
Case Reports and Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557110/
https://www.ncbi.nlm.nih.gov/pubmed/36268055
http://dx.doi.org/10.1016/j.clinpr.2022.100207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557110/
https://www.ncbi.nlm.nih.gov/pubmed/36268055
http://dx.doi.org/10.1016/j.clinpr.2022.100207

Ejemplares similares